Q2 2026 revenue

Subject kind: financing
Statement date: 2026-08-11
Promised amount: 2.58 billion USD
Current status: stated

The claim, verbatim

Second-quarter revenue was $2.58 billion, up 112% year-over-year, surpassing analyst estimates of $2.56 billion

Source (primary)

‘Pharma Bro’ Martin Shkreli ‘Covered’ CoreWeave Short Position: CRWV Stock Slides For Third Session - Stocktwits (-, news_article)
View cached copy (2026-08-31)Live source ↗Archive.org ↗

Quote: “CoreWeave's second-quarter revenue increased 112% to $2.58 billion, surpassing analysts' estimates of $2.56 billion, according to results issued on Aug. 11.”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms ‘Pharma Bro’ Martin Shkreli ‘Covered’ CoreWeave Short Position: CRWV Stock Slides For Third Session - Stocktwits

Quote: “CoreWeave's second-quarter revenue increased 112% to $2.58 billion, surpassing analysts' estimates of $2.56 billion, according to results issued on Aug. 11.”

View cached copy (2026-08-31)Live source ↗Archive.org ↗

Record of changes

August 31, 2026 — statedlater found incorrect

Automated extraction from the cited source. ~~Recorded automatically from the cited source when it was published, then queued for evidence review.~~

September 1, 2026 — withdrawnlater found incorrect

Evidence review against the cited source. ~~The source confirms quarterly results were reported but contains no specific revenue figures, year-over-year growth rates, or analyst estimate comparisons.~~

September 2, 2026 — stated

Correction after re-verification. Re-verification found the cited source does support this claim. The earlier withdrawal was made in error and has been reversed. The attributed quote appears verbatim in the cited source (deterministic check).